Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02934568
Title Ribociclib (LEE011) Rollover Study for Continued Access
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult | child
Covered Countries USA | FRA | ESP

Facility Status City State Zip Country Details
University of Alabama at Birmingham COMPLETED Birmingham Alabama 35294-3300 United States Details
Dana Farber Cancer Institute Main Site COMPLETED Boston Massachusetts 02215 United States Details
The Regents of the University of Michigan COMPLETED Ann Arbor Michigan 48109-5930 United States Details
Broome Oncology SC-2 COMPLETED Johnson City New York 13790 United States Details
St Jude Children's Research Hospital RECRUITING Memphis Tennessee 38105 United States Details
Novartis Investigative Site COMPLETED Lyon 69373 France Details
Novartis Investigative Site COMPLETED Villejuif 94800 France Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Singapore 119228 Singapore Details
Novartis Investigative Site WITHDRAWN Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Madrid 28041 Spain Details
Novartis Investigative Site COMPLETED Madrid 28050 Spain Details
Novartis Investigative Site RECRUITING Tainan 70403 Taiwan Details
Novartis Investigative Site COMPLETED Taipei 10002 Taiwan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field